Can a 15-month-old who has received three prior Pentacel (DTaP‑IPV‑Hib) doses at 2, 4, and 6 months receive the fourth booster dose now?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Yes, a 15-month-old can receive the fourth dose of Pentacel now

A 15-month-old who received Pentacel at 2,4, and 6 months should receive the fourth dose at 15-18 months of age. This is the standard recommended schedule and is explicitly supported by both FDA labeling and ACIP guidelines.

Recommended Timing and Schedule

According to the FDA-approved Pentacel label, the vaccine is administered as a 4-dose series at 2,4,6, and 15-18 months of age 1. The first dose may be given as early as 6 weeks, and the vaccine is approved for use through 4 years of age (prior to the fifth birthday) 1.

ACIP guidelines from 2007 specify that the fourth dose of DTaP may be administered as early as age 12 months, provided 6 months have elapsed since the third dose 2. Since your patient received the third dose at 6 months, administering the fourth dose at 15 months provides a 9-month interval, which exceeds the minimum requirement.

Important Considerations for the Complete Immunization Series

Fifth Dose Requirement

After completing the 4-dose Pentacel series, this child will need a fifth dose of DTaP vaccine at 4-6 years of age 3. This fifth dose should be given using either DAPTACEL or Quadracel—not Pentacel, as Pentacel is not indicated for the booster dose at 4-6 years 1.

IPV Series Completion

When Pentacel is used for all four doses at 2,4,6, and 15-18 months, an additional booster dose of IPV-containing vaccine (either standalone IPV or DTaP-IPV) should be administered at age 4-6 years 3. This results in a 5-dose IPV series, which is considered acceptable by ACIP. The minimum interval from the fourth to fifth IPV dose should be at least 6 months 3.

Hib Series Completion

The four doses of Pentacel complete the Hib vaccination series. No additional Hib vaccine is needed after the fourth dose of Pentacel given at 15-18 months 4, 1.

Administration Details

  • Route: Intramuscular injection 1
  • Site: Anterolateral thigh (preferred in children <1 year) or deltoid muscle in older children 1
  • Dose: 0.5 mL after reconstitution of the lyophilized ActHIB component with the liquid DTaP-IPV component 1
  • Timing: Can be given any time between 15-18 months; no need to wait until 18 months

Common Pitfall to Avoid

Do not assume that four doses of Pentacel complete all immunization requirements. Parents must understand that two additional doses are still needed: a fifth DTaP dose and a fifth IPV dose at 4-6 years of age. Failure to communicate this results in incomplete immunization series and leaves children vulnerable to vaccine-preventable diseases during early school years.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.